Brianna Heaviside, BS

Precision NextGen Oncology and Research Center

Poster(s):

• (P 230) CIRCULATING TUMOR DNA AS AN EARLY INDICATOR OF RESPONSE, PROGRESSION, AND RECURRENCE OF SARCOMAS

• (P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS

• (P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA

• (P 471) COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL: A HIGHLY EFFICACIOUS AND BETTER TOLERATED OPTION FOR ANGIOSARCOMA